The median interval between starting infliximab and the development of infection was only 12 weeks; this finding supports the contention that the use of this TNF inhibitor is strongly associated with the reactivation of latent tuberculosis into secondary tuberculosis. This evidence concerns the gene TNF and tuberculosis.